Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Invitae Corp (NVTA)

Invitae Corp (NVTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Invitae Corp Up 43.4% Since SmarTrend Uptrend Call (NVTA)

SmarTrend identified an Uptrend for Invitae Corp (NYSE:NVTA) on January 15th, 2020 at $18.90. In approximately 1 month, Invitae Corp has returned 43.40% as of today's recent price of $27.09.

NVTA : 27.04 (+3.01%)
SmarTrend Watching for Potential Pullback in Shares of Invitae Corp After 4.10% Gain

Invitae Corp (NYSE:NVTA) traded in a range yesterday that spanned from a low of $24.34 to a high of $25.35. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $24.35...

NVTA : 27.04 (+3.01%)
Watch for Invitae Corp to Potentially Pullback After Gaining 5.19% Yesterday

Invitae Corp (NYSE:NVTA) traded in a range yesterday that spanned from a low of $22.23 to a high of $23.54. Yesterday, the shares gained 5.2%, which took the trading range above the 3-day high of $23.39...

NVTA : 27.04 (+3.01%)
Invitae Corp has the Best Relative Performance in the Biotechnology Industry (NVTA , GILD , REGN , CLVS , DVAX )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

GILD : 67.56 (+1.14%)
NVTA : 27.04 (+3.01%)
REGN : 399.55 (+0.19%)
Invitae to announce fourth quarter and full year 2019 financial results on February 19, 2020

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its fourth quarter and full year 2019 financial results on Wednesday, February 19, 2020 and will...

NVTA : 27.04 (+3.01%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CLVS , NVTA , CYTK , UTHR , ALNY )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

CLVS : 9.44 (-2.78%)
CYTK : 14.85 (-3.63%)
NVTA : 27.04 (+3.01%)
Invitae Corp Set to Possibly Pullback After Yesterday's Rally of 5.23%

Invitae Corp (NYSE:NVTA) traded in a range yesterday that spanned from a low of $18.76 to a high of $19.94. Yesterday, the shares gained 5.2%, which took the trading range above the 3-day high of $18.97...

NVTA : 27.04 (+3.01%)
Implied Volatility Surging for Invitae (NVTA) Stock Options

Investors need to pay close attention to Invitae (NVTA) stock based on the movements in the options market lately.

NVTA : 27.04 (+3.01%)
Relatively Good Performance Detected in Shares of Akebia Therapeut in the Biotechnology Industry (AKBA , FOLD , NVTA , BPMC , CTMX )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

AKBA : 8.75 (-2.78%)
FOLD : 10.98 (+0.09%)
NVTA : 27.04 (+3.01%)
Watch for Invitae Corp to Potentially Pullback After Gaining 7.72% Yesterday

Invitae Corp (NYSE:NVTA) traded in a range yesterday that spanned from a low of $17.51 to a high of $18.53. Yesterday, the shares gained 7.7%, which took the trading range above the 3-day high of $17.12...

NVTA : 27.04 (+3.01%)
Invitae preliminary 2019 financial results demonstrate strong momentum with nearly 60% growth in test volume and more than 45% growth in revenue year-over-year

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, announced preliminary unaudited full-year 2019 results, driving strong growth in volume and revenues, signaling continued momentum...

NVTA : 27.04 (+3.01%)
Behind the Seizure® Program Further Expands Access to Genetic Testing for Children to Speed the Diagnosis of Genetic Epilepsy

Today BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) and Invitae Corporation (NYSE: NVTA) announced that Biogen (NASDAQ: BIIB), Encoded Therapeutics, Neurogene, Praxis Precision Medicines and PTC Therapeutics...

PTCT : 57.75 (+1.73%)
BMRN : 89.01 (+0.87%)
BIIB : 333.00 (-0.37%)
NVTA : 27.04 (+3.01%)
STOK : 26.89 (-4.48%)
Invitae to Present at the 38th Annual J.P. Morgan Healthcare Conference

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that Sean George, co-founder and chief executive officer of Invitae, will present at the 38th Annual J.P. Morgan Healthcare...

JPM : 137.46 (-0.30%)
NVTA : 27.04 (+3.01%)
Small Gains Still Bring New Records

Small Gains Still Bring New Records

CDAY : 73.68 (+1.81%)
WWE : 44.93 (+2.67%)
ERI : 68.93 (+1.35%)
WYNN : 132.14 (-1.11%)
GH : 84.30 (+3.06%)
NVTA : 27.04 (+3.01%)
KERN : 7.09 (+0.42%)
RCEL : 10.85 (+4.43%)
Invitae Announces Program with BioMarin to Expand Access to Genetic Testing for Skeletal Dysplasias

Invitae (NYSE: NVTA), a leading medical genetics company, today announced the launch of Discover Dysplasias(TM), an initiative with BioMarin Pharmaceutical to offer genetic testing at no charge to patients...

NVTA : 27.04 (+3.01%)
Bull of the Day: Guardant Health (GH)

Bull of the Day: Guardant Health (GH)

NVTA : 27.04 (+3.01%)
GH : 84.30 (+3.06%)
Stocks Rebound and Hang Onto Recent Gains

Stocks Rebound and Hang Onto Recent Gains

ORI : 23.49 (+0.38%)
AOBC : 10.21 (-0.49%)
RLGY : 12.68 (-0.39%)
BLUE : 89.31 (-0.21%)
TRHC : 64.38 (+0.19%)
NVTA : 27.04 (+3.01%)
NGM Bio Announces Appointment of Shelly Guyer to Board of Directors

NGM Biopharmaceuticals, Inc. (Nasdaq: NGM), a clinical stage biotechnology company focused on developing transformative therapeutics for patients, today announced the expansion of its Board of Directors...

NGM : 16.77 (+3.58%)
NVTA : 27.04 (+3.01%)
Look for Shares of Invitae Corp to Potentially Rebound after Yesterday's 5.53% Sell Off

Invitae Corp (NYSE:NVTA) traded in a range yesterday that spanned from a low of $18.72 to a high of $19.90. Yesterday, the shares fell 5.5%, which took the trading range below the 3-day low of $19.40...

NVTA : 27.04 (+3.01%)
SmarTrend Watching for Potential Rebound in Shares of Invitae Corp After 2.87% Loss

Invitae Corp (NYSE:NVTA) traded in a range yesterday that spanned from a low of $19.54 to a high of $20.15. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $19.60...

NVTA : 27.04 (+3.01%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS +0.89 , SEDG +0.05 , THC -0.57 , TER -2.42 , LITE -3.44
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar